This statistic depicts the possible cost savings that could be gained from participating in a phase 2 oncology master protocol as of 2018. According to the source, total cost savings could be as high as 1.6 million U.S. dollars.
Possible cost savings from phase 2 oncology master protocol participation as of 2018
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Deloitte. (January 22, 2019). Possible cost savings from phase 2 oncology master protocol participation as of 2018 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/
Deloitte. "Possible cost savings from phase 2 oncology master protocol participation as of 2018 (in million U.S. dollars)." Chart. January 22, 2019. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/
Deloitte. (2019). Possible cost savings from phase 2 oncology master protocol participation as of 2018 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/
Deloitte. "Possible Cost Savings from Phase 2 Oncology Master Protocol Participation as of 2018 (in Million U.S. Dollars)." Statista, Statista Inc., 22 Jan 2019, https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/
Deloitte, Possible cost savings from phase 2 oncology master protocol participation as of 2018 (in million U.S. dollars) Statista, https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/ (last visited December 21, 2024)
Possible cost savings from phase 2 oncology master protocol participation as of 2018 (in million U.S. dollars) [Graph], Deloitte, January 22, 2019. [Online]. Available: https://www.statista.com/statistics/973374/cost-savings-phase-2-oncology-master-protocol/
